ZA9811554B - Method for production of human leukocyte (alpha) interferon - Google Patents
Method for production of human leukocyte (alpha) interferonInfo
- Publication number
- ZA9811554B ZA9811554B ZA9811554A ZA9811554A ZA9811554B ZA 9811554 B ZA9811554 B ZA 9811554B ZA 9811554 A ZA9811554 A ZA 9811554A ZA 9811554 A ZA9811554 A ZA 9811554A ZA 9811554 B ZA9811554 B ZA 9811554B
- Authority
- ZA
- South Africa
- Prior art keywords
- sendai virus
- interferon
- induction
- suspension
- culture medium
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title abstract 2
- 108010050904 Interferons Proteins 0.000 title abstract 2
- 229940079322 interferon Drugs 0.000 title abstract 2
- 210000000265 leukocyte Anatomy 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 241000711408 Murine respirovirus Species 0.000 abstract 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 239000001963 growth medium Substances 0.000 abstract 2
- 238000011534 incubation Methods 0.000 abstract 2
- 230000006698 induction Effects 0.000 abstract 2
- 238000009630 liquid culture Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- 206010018910 Haemolysis Diseases 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 235000019270 ammonium chloride Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000008588 hemolysis Effects 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000002203 pretreatment Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9800554A HU222980B1 (hu) | 1998-03-13 | 1998-03-13 | Eljárás humán Alfa-interferon előállítására |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9811554B true ZA9811554B (en) | 1999-02-17 |
Family
ID=89996253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9811554A ZA9811554B (en) | 1998-03-13 | 1998-12-17 | Method for production of human leukocyte (alpha) interferon |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6156542A (de) |
| EP (1) | EP0945463B1 (de) |
| JP (1) | JPH11253192A (de) |
| AT (1) | ATE299893T1 (de) |
| CA (1) | CA2234396C (de) |
| DE (1) | DE69830895D1 (de) |
| HU (1) | HU222980B1 (de) |
| ZA (1) | ZA9811554B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6472208B1 (en) * | 1999-12-13 | 2002-10-29 | Héma-Québec | Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3800035A (en) * | 1971-12-07 | 1974-03-26 | Smithkline Corp | Production of interferon from human leukocytes in the absence of serum |
| HU192254B (en) * | 1983-12-13 | 1987-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing human leucocite and human gamma interferons in consecutive steps |
| HUT40576A (en) * | 1984-09-21 | 1987-01-28 | Vnii Chistykh Bio | Process for producing human leucocite interferon |
| JP2888443B2 (ja) * | 1989-12-07 | 1999-05-10 | 日本ケミカルリサーチ株式会社 | ヒト白血球インターフェロン亜種の抗体の製造法及び測定法 |
-
1998
- 1998-03-13 HU HU9800554A patent/HU222980B1/hu not_active IP Right Cessation
- 1998-05-08 EP EP98108457A patent/EP0945463B1/de not_active Expired - Lifetime
- 1998-05-08 DE DE69830895T patent/DE69830895D1/de not_active Expired - Lifetime
- 1998-05-08 CA CA002234396A patent/CA2234396C/en not_active Expired - Fee Related
- 1998-05-08 AT AT98108457T patent/ATE299893T1/de not_active IP Right Cessation
- 1998-05-12 US US09/076,194 patent/US6156542A/en not_active Expired - Fee Related
- 1998-12-17 ZA ZA9811554A patent/ZA9811554B/xx unknown
-
1999
- 1999-01-18 JP JP11009879A patent/JPH11253192A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE299893T1 (de) | 2005-08-15 |
| US6156542A (en) | 2000-12-05 |
| DE69830895D1 (de) | 2005-08-25 |
| JPH11253192A (ja) | 1999-09-21 |
| CA2234396A1 (en) | 1999-09-13 |
| HUP9800554A3 (en) | 2000-12-28 |
| EP0945463A3 (de) | 2001-02-07 |
| EP0945463A2 (de) | 1999-09-29 |
| HU9800554D0 (en) | 1998-05-28 |
| CA2234396C (en) | 2002-11-05 |
| HUP9800554A2 (hu) | 1999-12-28 |
| EP0945463B1 (de) | 2005-07-20 |
| HU222980B1 (hu) | 2004-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94045873A (ru) | Композиция альфа-интерферона и способ ее получения из лейкоцитов крови человека | |
| DE69637486D1 (de) | 'Osteoclast-Inhibitor Faktor' (OCIF) abgeleitete Proteinen und Methoden zu dessen Gewinnung | |
| EP0000520A1 (de) | Verbessertes Verfahren zur Herstellung von Interferon | |
| ATE256182T1 (de) | Neuartiges p- selectin ligandenprotein | |
| KR880000465A (ko) | 순수한 알부민의 제조방법 | |
| HU9203659D0 (en) | Preparative and method for influencing activithy of rna by means of modifying structure of rna 5'-cap | |
| ATE43639T1 (de) | Verfahren zur entfernung von verunreinigungen aus leukozytinterferon-zubereitungen und das so hergestellte gereinigte leukozytinterferon. | |
| ATE62133T1 (de) | Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion. | |
| SU1713591A1 (ru) | Способ получени человеческого лейкоцитарного интерферона | |
| HU9800554D0 (en) | Process for producing human leukocyte (alpha) interferon | |
| US4780413A (en) | Production of antiviral agents | |
| ATE154611T1 (de) | Neuer megakaryokytischer koloniestimulierender faktor und verfahren zur herstellung | |
| ATE44750T1 (de) | Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats. | |
| NO960766L (no) | Nytt protein og fremgangsmåte for fremstilling av dette | |
| FR2548671B1 (fr) | Procede de preparation de globine a partir d'hemoglobine et globine obtenue par ce procede | |
| RU97109525A (ru) | Препарат "локферон" для лечения и профилактики вирусных заболеваний и способ его получения | |
| ATE251640T1 (de) | Neues chondrozytprotein | |
| DE68913212D1 (de) | Ein reines faktor i-protein und verfahren zur herstellung. | |
| JPS6031479B2 (ja) | 純コンドロイチナ−ゼcの製造法 | |
| SU1681426A1 (ru) | Способ получения вещества, восстанавливающего дыхательную функцию легких | |
| KR850000145B1 (ko) | B형 간염 바이러스 표면 항원의 분리 정제방법 | |
| RU93019436A (ru) | Способ получения человеческого лейкоцитарного интерферона | |
| JPH0216994A (ja) | 細胞増殖阻害因子及びその製造方法 | |
| JPS5643218A (en) | Preparation of gamma-globulin for intravenous injection | |
| EP0073248A1 (de) | Verfahren zur herstellung von interferon sowie interferon in komplex mit antibakteriellen und antitoxischen substanzen |